ft596: ipsc-derived car-nk cells with engineered persistence for b-cell malignancies
Published 4 years ago • 2.8K plays • Length 8:54Download video MP4
Download video MP3
Similar videos
-
3:18
allogeneic car-nk cell therapy in r/r aml/mds
-
1:06
car-nk for b-cell malignancies: the elipse-1 study of cnty-101
-
2:01
cellular therapy: nk-cells as a model
-
2:56
car-nk clinical trials
-
1:49
are car nk-cells the future of cll therapy?
-
2:01
allocars and car-nk cells in myeloma
-
2:20
car-transduced nk cell therapy
-
3:42
anti-cd38 car nk-cells: an off-the shelf therapy for multiple myeloma
-
1:28
future prospects for nk cell therapy
-
1:03
addressing car-nk unknowns
-
1:46
using nk cells to treat cancer
-
0:40
the current status of car t and car nk cells in multiple myeloma
-
1:11
the future of cord blood-derived nk cells and how their persistence can be improved
-
0:58
update on car-nk cell therapy work at md anderson
-
0:59
next steps for gene-edited nk cells in the treatment of hematological malignancies
-
3:05
lentivirally and alpharetrovirally engineered cd19 nk car-cells in all
-
5:14
nk-cell enhancement: trail variant
-
3:17
tgfb-resistant nk cells for hematological malignancies